Trabodenoson

DB13122InvestigationalSmall molecule

Trabodenoson has been used in trials studying the treatment of Ocular Hypertension (OHT) and Primary Open-Angle Glaucoma (POAG).

Chemical structure of Trabodenoson
Mechanism
Curator reviewed
Formula / weight
C15H20N6O6 · 380.361 g/mol (avg)
Code names
INNO-8875 · INO-8875

Resolves to

Compound
UNII1T237110W4CAS871108-05-3ChEMBLCHEMBL3545407PubChem11610599
Structure
InChIKeyAQLVRTWKJDTWQQ-SDBHATRESA-NSMILESO[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@H]([C@@H]1O)N1C=NC2=C(NC3CCCC3)N=CN=C12
Targets
P30542ADORA1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Trabodenoson, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In